© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
The story of 4-Piperidone monohydrate hydrochloride traces back to the rise of synthetic chemistry in the twentieth century. Back then, research laboratories in Europe and North America rushed to develop new chemical scaffolds as foundations for medicines, crop-protectants, and dyes. Among these, nitrogen-containing rings—called piperidines—offered not only structural curiosity but practical utility. In my years working with academic and industry chemists, the name 4-piperidone came up often, a respected precursor for pharmaceuticals and bioactive molecules. Seeing the compound gain a place in medicinal chemistry felt like watching a sturdy, unglamorous tool quietly shape outcomes far beyond its footprint.
Talking about 4-Piperidone monohydrate hydrochloride, most folks imagine a white or off-white crystalline powder that doesn't draw attention. Yet, its real value emerges in the hands of skilled scientists who convert it into molecules that touch lives—pain medications, compounds for central nervous system disorders, or research chemicals. While it doesn’t dominate headlines, the sheer number of routes built off its skeleton underscores its importance in the lab. Hundreds of academic publications and patents remind us that this chemical, tucked on the shelf, forms the backbone for discoveries year after year.
This compound offers a manageable profile in the laboratory. It usually arrives as a stable, crystalline solid, readily soluble in water and polar solvents. That helps with ease of weighing and dissolving, which can't be understated in bench work. Its chemical stability lets researchers store it with fewer worries about degradation. The hydrochloride hydrate form adds another layer of convenience, improving safety and shelf-life compared to its free base counterpart. This practical stability means labs can come back to the same bottle for months, or even years, and trust the chemistry will stay predictable.
In regulated environments, reliable identification and documentation matter as much as the properties of the compound itself. Working in labs where accuracy underpins every step, I learned that clear labeling is more than bureaucracy. For 4-piperidone monohydrate hydrochloride, industry standards demand clear information: chemical name, concentration, batch or lot number, and purity level. Most reputable vendors deliver this with certificates of analysis that summarize spectral identification and impurity profiles. That detailed record enables traceability and accountability, two anchors of good research practice. Without such information, downstream projects risk delays, errors, or, worst of all, wasted resources.
Chemists approach the synthesis of 4-piperidone monohydrate hydrochloride through routes that balance efficiency, cost, and safety. In supervised research environments, classic organic reactions form the basis for its production. Processes usually start from piperidine, an affordable cyclic amine, through selective oxidation or deprotection strategies. Environmental and safety concerns push researchers to pick routes that minimize hazardous by-products or tricky purification steps. Having spent time working at the hood, the value of procedures that cut unnecessary solvent exchanges, or avoid harsh reagents, always stood out. There are modern efforts to make such syntheses greener, but progress depends on both economic and regulatory pressures.
As a versatile intermediate, 4-piperidone monohydrate hydrochloride invites modification. Chemists react its carbonyl group with nucleophiles, convert the amine, or build larger ring systems from its scaffold. One cannot ignore its pivotal role in the synthesis of pharmaceuticals like fentanyl, or a long tail of related analogs. In academic projects, its ability to act as a platform for multiple transformations keeps interest strong. The compound’s reactivity means a skilled chemist can guide it down many synthesis paths, each leading to new or improved molecules that drive innovation in opioid medications and other drugs.
In chemical catalogs and journal articles, 4-piperidone monohydrate hydrochloride appears under several names. Variants reflect structure or hydration state, like “piperidin-4-one hydrochloride hydrate” or “4-oxo-piperidine HCl monohydrate.” Recognizing the different aliases proves crucial when cross-referencing papers, patents, or vendor sheets. Casual mix-ups between nomenclature often lead to missed connections or even costly mistakes, something many researchers learn the hard way—myself included. A good practice remains to check molecular weight, CAS number, and spectral data to confirm you’re holding the right compound regardless of the label attached.
Safety deserves direct attention. In my early chemistry days, glove and goggle routines became second nature, especially around alkaloid precursors like 4-piperidone monohydrate hydrochloride. The compound typically causes irritation if inhaled or if it contacts skin and eyes, so fume hoods, PPE, and proper training anchor sound handling. Standard operating procedures focus on minimizing exposure and preventing accidental ingestion or environmental release. Industry best practices recommend careful documentation, proactive spill planning, and secure storage to prevent unauthorized use. Attention to these details means safer outcomes and underscores the difference between responsible science and preventable hazard.
The main arena for 4-piperidone monohydrate hydrochloride lies in small molecule synthesis. Pharmaceutical companies and academic labs rely on it for medicinal chemistry projects, where it acts as a building block for diverse drugs. Custom synthesis firms use it to develop libraries of analogs for biological screening. Some government agencies flag the substance as a controlled chemical because of its link to the production of opioids and related drugs. This dual role, as an engine for progress and as a potential risk, shapes discussions about access and oversight. More recently, chemical biologists have explored its use in probe design and covalent inhibitor development, pushing the compound into fertile new fields beyond its legacy role in analgesic research.
The steady flow of publications and patents revolving around 4-piperidone monohydrate hydrochloride highlights its research value. New synthetic routes, protecting group strategies, and functionalizations drive improvements year by year. In my collaborations with medicinal chemists, we’ve puzzled through modifications meant to unlock safer or more selective therapies, always circling back to this core intermediate. Innovation in this field works like a relay race: each new derivative builds on proven chemistry but refines potency, selectivity, or metabolic behavior. Researchers focus not just on “what can we make?” but “what can we make better, safer, with less waste?” and the modest piperidone ring continues to answer with new possibilities.
Discussions of toxicity cannot be sidelined. Many in the field pay close attention to the potential hazards associated with 4-piperidone monohydrate hydrochloride, both from a personal safety perspective and for broader societal concerns. In laboratory settings, the compound hasn’t drawn excessive alarm—risks mainly center on irritation, much like other small molecule intermediates. On the public health side, its key role as a precursor for potent opioids draws scrutiny. Governments and watchdogs demand vigilance to prevent diversion or misuse. Responsible research means continuous evaluation of risks, open publication of toxicological findings, and a willingness to adapt protocols as evidence accumulates.
Looking ahead, I expect 4-piperidone monohydrate hydrochloride to remain a fixture in organic synthesis, even as technology and regulation evolve. The increasing focus on green chemistry could drive the development of cleaner manufacturing routes with fewer hazardous by-products. On the regulatory front, companies and universities may see tighter controls and more oversight concerning storage and documentation. In drug discovery, the search for novel scaffolds still brings scientists back to old standbys, and this piperidone derivative continues to deliver. What stands out most is the need for strong communication between researchers, regulatory agencies, and the broader public—balancing innovation and safety so that valuable tools like this don’t become liabilities. The actions taken today will shape whether chemists in the next decade see this compound as a badge of progress or as a source of cautionary tales.
Every so often a compound, not known outside research circles, ends up playing a significant role in how things unfold behind the scenes. 4-Piperidone Monohydrate Hydrochloride is one of these chemicals. You may not see its name in a list of household items or in any over-the-counter bottle. Still, it supports crucial work in the lab, driving development in both medical and scientific communities.
4-Piperidone Monohydrate Hydrochloride isn’t found in the wild or in your kitchen. Chemists use it as a building block in the synthesis of more complex molecules, particularly in drug development. This substance pops up often in the early stages of creating medicines for treating tough illnesses, including some cancers and infections. Research laboratories depend on it to help assemble molecules designed to target disease right at its roots.
The magic of the compound comes from its molecular ring structure, which helps scientists construct new molecules with ease. This single feature supports the process of medicinal chemistry, where tiny changes can mean the difference between a breakthrough therapy and a failed experiment. I’ve noticed from my own conversations with research pharmacists that chasing new ways to block or slow disease often means starting with these sorts of well-designed core molecules.
Certain chemicals—4-Piperidone Monohydrate Hydrochloride included—pose safety and ethical questions. Because this compound sits at the start of many synthetic routes, some people worry about misuse. Law enforcement and global health agencies monitor its trade, as some illegal labs pursue it for making controlled substances. This concern is real and has led to calls for tighter regulation and better tracking. It’s a classic balance: push for innovation while avoiding unintended harm.
As a journalist who has interviewed law enforcement officers and regulatory experts, I’ve seen how a lack of oversight can open doors to trafficking in dangerous goods. Responsible sourcing and transparent supply chains give both scientists and regular people a sense that rules are followed. At the same time, red tape must not choke off progress for doctors and researchers searching for new cures.
The laboratory world often feels disconnected from daily life, but what happens there shapes the treatments people count on. Reliable oversight stands as a top priority, not just for the authorities but for companies and scientists themselves. Investing in real-time tracking technology for chemical shipments, regular audits, and global cooperation can keep things fair. It also helps build trust between the public and the research community.
On the science side, emphasis on teaching ethical handling matters. Many universities now weave chemical ethics into their training programs, so the next wave of researchers grasps why accountability and safety go hand in hand. More awareness about how essential chemicals like 4-Piperidone Monohydrate Hydrochloride support critical research, along with respect for how they’re used, paves the way forward.
Keeping a watchful eye while supporting honest discovery keeps both patients and researchers in mind, making sure hope keeps arriving—one molecule at a time.
Chemicals don't make the news by accident. 4-Piperidone monohydrate hydrochloride grabs headlines not for its presence in a beaker, but for what happens to it on its way to more potent products. As someone who has followed chemical safety and law for years, I’ve seen how this substance links directly to both industry and crime. It is a middle step, not the end goal—an intermediate used in creating medicines and, less legally, illicit drugs. That means it represents a crossroads for regulation.
Authorities around the world track certain chemicals with hawk-like attention. I’ve learned from watching cases and reading up on enforcement reports that 4-piperidone monohydrate hydrochloride falls under the microscope. In the United States, the Drug Enforcement Administration calls it a List I chemical. This label doesn’t come easy. Substances making the list have strong connections to controlled substances—fentanyl, for example—often used in their manufacturing.
Getting your hands on this chemical means paperwork, identification, permits, and maybe a knock at your door from people with badges if things look suspicious. For people who make legitimate products such as pharmaceuticals, this means a whole extra layer of paperwork and record-keeping that can slow down research but helps weed out bad actors. According to the DEA, companies must report transactions and keep records for at least two years. These requirements don’t just slow the flow; they leave a trail investigators can follow.
Travel beyond the US, and rules shift. The United Nations Office on Drugs and Crime lists chemicals with links to narcotics production, pushing countries to set up barriers against illegal usage. Some countries—Canada, Australia, China—place this compound under special control. Others lag, creating holes in the fence for traffickers and suppliers eager to find the path of least resistance. I have spoken with chemists and regulators at conferences who worry that every rule in one country can lead to demand in another less regulated market.
Enforcement is never airtight. Online markets pop up, engines of commerce move quick, and a delay of even months in adding a chemical to a restricted list opens doors for those hoping to game the system. My own deep dive into enforcement databases shows cases where seizures carry not the chemical itself, but written orders, ingredients, or equipment ready for rapid synthesis.
Striking the balance between industry and public safety runs through every conversation on chemical regulation. I have heard frustrated researchers talk about regulatory hurdles, but as a consumer and community member, I see street fentanyl statistics and understand the pain behind those numbers. Effective regulation means not just making lists, but sharing information across borders, watching supply chains, and supporting research into safe alternatives.
Some solutions already show promise. Improved digital tracking in shipping helps flag suspicious orders. International task forces can jump on trafficking trends rather than chasing behind. Education matters too—when small labs and suppliers know the impact of failing to ask questions, they become frontline defenders rather than accidental accomplices.
Chemicals like 4-piperidone monohydrate hydrochloride are reminders that science and society bump into each other every day. How countries choose to regulate this compound shapes not just a lab’s workflow, but the health and safety of whole communities. That’s a responsibility nobody in science or policy can dodge.
4-Piperidone Monohydrate Hydrochloride serves as a crucial ingredient in chemical synthesis and pharmaceutical research. Many people focus on its uses, but a lot gets overlooked about what it takes to store this substance safely. A few years on the research bench taught me that careless storage ruins chemicals before you even open the bottle. Too much moisture, light, or variation in temperature can turn a reliable reagent into a wild card in experiments or manufacturing runs. That leads to failed reactions, wasted budgets, and plenty of headaches.
With 4-Piperidone Monohydrate Hydrochloride, the label tells only part of the story. Most suppliers indicate a cool, dry, and well-ventilated place away from direct sunlight. But what does that look like in practice? Experience shows that storing it in a climate-controlled cabinet away from heat sources improves its shelf life dramatically. The monohydrate form especially tends to attract moisture from air, so simple steps such as keeping the container tightly sealed and opening it only under dry conditions help keep the chemical stable.
Hygroscopic chemicals act like sponges, drawing water from air even when humidity feels low. Even if the jar stays capped for most of the workday, brief exposure in a muggy lab or warehouse can trigger clumping or chemical degradation. Silica gel packets or desiccators do a simple but effective job. One summer, our team paid the price for neglecting to refresh desiccants: we noticed shifts in melting points and odd smells after just two weeks in a humid storeroom. Lesson learned—moisture control is not optional.
Stable temperature also plays a big role in storage. Fluctuations—like those from HVAC systems cycling on and off—allow condensation in sealed containers, which leads right back to the problems moisture brings. Sticking with 2–8°C typically works well. Refrigerators reserved for chemicals, not shared with staff lunches, make it easier to manage. Light, especially ultraviolet, speeds up decomposition in some compounds. Storing away from windows and under low-intensity lighting pays off in higher reliability later.
Clear labeling saves time and prevents mistakes. Expiry dates, date of opening, storage requirements, and warnings belong right on the bottle or container. During busy seasons, I’ve seen even experienced colleagues mistakenly use outdated stocks because labeling got skipped in the rush. Labels stand up better on glass than plastic, but relabel if they start peeling. Precise documentation also satisfies inspectors, making regulatory headaches less likely.
Poor storage not only wastes money but risks health and safety. Chemicals breaking down can release hazardous byproducts or lose potency without warning. Every researcher or facility manager carries a responsibility to their team—and their local community—by keeping chemicals in good shape. I’ve seen fewer near-misses in workplaces that treat storage as a lab priority, not an afterthought. Training new staff on these methods also builds confidence and keeps small mistakes from turning into big problems later on.
Routine checks on storage areas and inventories stop small issues from piling up. Investing in dedicated climate controls saves money compared to scrapping ruined batches. Bringing everyone into the conversation—from procurement to the lab floor—helps catch small gaps in practice or policy before they cause trouble. An effective storage system often grows from shared experience and a steady hand more than fancy technology.
4-Piperidone monohydrate hydrochloride brings together the building blocks of medicinal chemistry. In plain terms, this compound’s backbone comes from piperidine, a six-membered ring with five carbons and one nitrogen atom. On the fourth carbon, an oxygen atom forms a double bond, creating a "keto" group. The "monohydrate" shows a water molecule joins the crystal lattice, and the "hydrochloride" points to a chloride ion balancing the charge, stemming from hydrochloric acid.
The chemical formula adds up to C5H9NO · HCl · H2O. Its structural details break down like this: five carbon atoms, one nitrogen, one oxygen, one hydrogen chloride, and one molecule of water. Chemists picture it as a piperidine ring (C5H9N) with a double-bonded oxygen on the fourth carbon, hydrated, and hydrochloride salt stabilized.
This compound isn’t just a bit of trivia for chemical catalogs. 4-Piperidone derivatives form stepping stones for pharmaceutical research, especially in the synthesis of drugs targeting neurological conditions. Laboratories reach for this intermediate because its structure supports transformations into dozens of biologically active molecules—including compounds for pain management and central nervous system therapies.
Many modern medicines trace their routes back through molecules like 4-piperidone, as its chemical backbone gives flexibility for creating novel substances. The pharmaceutical industry values its stable crystal structure—boosted with the monohydrate and hydrochloride forms—since it stores predictably and reacts with a broad range of chemical partners. Research teams focus on reliability and reproducibility, and 4-piperidone’s stability checks both boxes.
For years, chemical suppliers have produced 4-piperidone monohydrate hydrochloride for research and manufacturing. Handling the substance requires care because piperidone derivatives belong to precursor lists in several countries, due to possible misuse in the synthesis of illicit drugs. Regulatory measures aren’t just bureaucratic hurdles—they push researchers and buyers to track their inventory, flag potential diversions, and follow proper documentation.
I remember stricter registration protocols swimming into focus every time a new regulation cropped up, especially as authorities learned to balance legitimate scientific pursuits with law enforcement interests. These safety standards help protect workers and communities—and people using downstream products—from risk and exposure. Following relevant storage, handling, and disposal guidelines makes the lab a safer space and one less likely to draw regulatory scrutiny.
Access to high-quality intermediates like 4-piperidone has major implications for drug development timelines. Supply chain disruptions hit researchers hard, especially those working on tight project deadlines or pursuing promising new treatments. People working in the supply side can address some challenges by partnering with reliable manufacturers with transparent records and rigorous safety protocols. Investing in staff training, inventory controls, and locked storage facilities also helps ensure these chemicals reach only those with valid uses in medicine and research.
Continued education and responsible practice make it possible to harness the benefits of compounds like 4-piperidone monohydrate hydrochloride, while reducing chances for misuse. Scientists who understand and respect these substances contribute not just to better research, but also to a more trustworthy and resilient scientific community.
Every lab or industrial setting brings its unique challenges, but chemicals like 4-Piperidone Monohydrate Hydrochloride command real respect. I’ve seen colleagues breeze past safety warnings, thinking a white powder can’t carry much threat. Chemical burns, allergic reactions, and eye injuries don’t care about how busy your day is. One wrong move can keep you out of work and cause headaches for everyone around you.
Basic lab coats and gloves block a lot of direct contact. For a compound like 4-Piperidone Monohydrate Hydrochloride, skipping gloves invites trouble. Nitrile or neoprene gloves put up a good barrier. Standard cotton or latex does not hold up the same way, especially during long handling sessions. After an old pair gave out on me during a solvent extraction, I learned quick: check them before every use and swap them at the first sign of weakness.
Goggles feel awkward at first, but eye protection isn’t optional. Powders drift, and nobody wants chemical dust in their eyes. Fitted splash goggles stand up to splashes better than basic safety glasses. Inhalation risks need more than a simple mask. I used to see dust floating up from not so much as pouring, and realized only a properly fitted N95 or P100 respirator keeps harmful particles out. Dust in the lungs feels like a slow burn — who wants that risk?
Ventilation isn’t just a luxury. Dry chemicals drift in the air, collecting around workspaces and vents. A chemical fume hood becomes a must. One time, a benchmate thought a quiet afternoon meant skipping the hood. A mild breeze from a cracked window pushed vapors into the room — nose and throat irritation became a rude awakening. Stick with a hood, even for short tasks, and keep airflow strong.
Keep surfaces easy to clean. I never lay out papers or clutter where chemical dust might settle. Dedicated trays, lined with disposable pads, catch spills. Sealable waste containers sit close by. Rinsing glassware and wiping benches right away means fewer worries later.
Label every container and keep a log of use. One misplaced beaker got someone in my lab a visit to the urgent care clinic — misidentified compounds, mistaken for harmless water. Color coding helps, but double-checking every time keeps surprises away. Safety training works best when it’s actually practiced, not just ticked off once a year.
Spills can and will happen. I’ve scrambled for the right spill kit, so now I keep absorbents, neutralizers, and protective equipment right on hand. Quick cleanup beats panic every time. Know where the eyewash and emergency shower stand and make sure they work — run them often.
No piece of lab equipment or chemical protocol matters if you cut corners. Wash hands after every session. Don’t snack or drink near chemical areas. Change out contaminated coats and gloves with regularity. It looks like small steps, but these routines kept my teams free from mishaps for most of my career.
Every time someone handles chemicals like 4-Piperidone Monohydrate Hydrochloride, the right habits outweigh fancy equipment. Staying sharp keeps everyone safer, healthier, and out of the emergency room.
| Names | |
| Preferred IUPAC name | 4-Oxopiperidine monohydrate hydrochloride |
| Other names |
Piperidin-4-one monohydrate hydrochloride 4-Piperidonemonohydrate hydrochloride 4-Oxopiperidine monohydrate hydrochloride |
| Pronunciation | /ˈfɔːr paɪˈpɛr.ɪˌdoʊn ˌmɒn.oʊˈhaɪ.dreɪt haɪˌdrɒˈklɔːr.aɪd/ |
| Identifiers | |
| CAS Number | 40064-34-4 |
| 3D model (JSmol) | `load =3D2U;` |
| Beilstein Reference | 1105857 |
| ChEBI | CHEBI:85355 |
| ChEMBL | CHEMBL142965 |
| ChemSpider | 8829822 |
| DrugBank | DB14015 |
| ECHA InfoCard | 28e3ff71-cc5e-4625-8b38-5a8dc7d43ad1 |
| EC Number | 206-541-7 |
| Gmelin Reference | 107494 |
| KEGG | C14394 |
| MeSH | D06NYV6255 |
| PubChem CID | 69999457 |
| RTECS number | UJ4375000 |
| UNII | A9B639KDZ6 |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C5H9NO·HCl·H2O |
| Molar mass | 222.72 g/mol |
| Appearance | White to Off-White Crystalline Powder |
| Odor | Odorless |
| Density | 0.97 g/cm3 |
| Solubility in water | Soluble in water |
| log P | -2.0 |
| Acidity (pKa) | 8.1 |
| Basicity (pKb) | 4.29 |
| Magnetic susceptibility (χ) | -5.9e-6 cm³/mol |
| Refractive index (nD) | 1.525 |
| Viscosity | Viscous liquid |
| Dipole moment | 4.05 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 151.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -3482 kJ/mol |
| Pharmacology | |
| ATC code | |
| Hazards | |
| Main hazards | Harmful if swallowed, inhaled, or absorbed through skin; causes skin, eye, and respiratory tract irritation. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS05,GHS07 |
| Signal word | Danger |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P332+P313, P337+P313, P362+P364 |
| NFPA 704 (fire diamond) | 3-2-1-ox |
| Flash point | 73.6°C |
| LD50 (median dose) | LD50 (oral, rat): 1140 mg/kg |
| NIOSH | US3563000 |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for 4-Piperidone Monohydrate Hydrochloride: Not established |
| REL (Recommended) | 0.01 mg/m³ |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Piperidine Piperidine hydrochloride N-Methylpiperidone 4-Piperidone 4-Piperidone hydrochloride 1-Benzyl-4-piperidone N-Formylpiperidone 2-Piperidone |
